Definition of Inotuzumab. Meaning of Inotuzumab. Synonyms of Inotuzumab

- Inotuzumab ozogamicin, sold under the brand name Besponsa, is an antibody-drug conjugate medication used to treat relapsed or refractory B-cell precursor...
- Inotuzumab, which was approved by the FDA for the treatment of relapsed or refractory B cell acute lymphoblastic leukemia in August 2017. Inotuzumab consists...
- trastuzumab and a taxane chemotherapy. The European Commission approved Inotuzumab ozogamicin as a monotherapy for the treatment of adults with relapsed...
- myeloid leukemia (AML). A second calicheamicin-linked monoclonal antibody, inotuzumab ozogamicin (marketed as Besponsa), an anti-CD22-directed antibody-drug...
- cytotoxic agent from the class of calicheamicins. Gemtuzumab ozogamicin Inotuzumab ozogamicin "マイロターグ点滴静注用5mg インタビューフォーム" [Myrotarg 5mg for intravenous drip...
- Drug class Targeted conditions Year approved (FDA) Year approved (EMA) Inotuzumab ozogamicin (Besponsa) Anti-CD22 monoclonal antibody-drug conjugate Relapsed...
- Dinutuximab beta Dostarlimab Durvalumab Elotuzumab Enfortumab vedotin Inotuzumab ozogamicin Ipilimumab Isatuximab Mirvetuximab soravtansine Mogamulizumab...
- Ficlatuzumab§ Flotetuzumab§ Gemtuzumab ozogamicin Glofitamab Imgatuzumab§ Inotuzumab ozogamicin Labetuzumab§ Lifastuzumab vedotin§ Lintuzumab§ Lorvotuzumab...
- Celltech and Wyeth that began in 1991. The same collaboration later produced inotuzumab ozogamicin. Celltech was acquired by UCB in 2004 and Wyeth was acquired...
- therapy. Anti-CD22 monoclonal antibodies have been developed, notably inotuzumab ozogamicin, approved by the FDA in 2017 for relapsed and refractory CD22-positive...